SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001493152-23-017939
Filing Date
2023-05-17
Accepted
2023-05-17 16:06:01
Documents
21

Document Format Files

Seq Description Document Type Size
1 formf-1.htm F-1 2667835
2 image_001.jpg GRAPHIC 9359
3 image_002.jpg GRAPHIC 41228
4 image_003.jpg GRAPHIC 23713
5 image_004.jpg GRAPHIC 29705
6 image_005.jpg GRAPHIC 9734
7 image_006.jpg GRAPHIC 25106
8 image_007.jpg GRAPHIC 11793
9 image_008.jpg GRAPHIC 15893
10 image_009.jpg GRAPHIC 10302
11 image_010.jpg GRAPHIC 12383
12 image_011.jpg GRAPHIC 31331
13 image_012.jpg GRAPHIC 18080
14 image_013.jpg GRAPHIC 5713
15 ex5-1.htm EX-5.1 102758
16 ex5-1_001.jpg GRAPHIC 172162
17 ex5-1_002.jpg GRAPHIC 98588
18 ex5-1_003.jpg GRAPHIC 15100
19 ex23-1.htm EX-23.1 7085
20 ex23-1_001.jpg GRAPHIC 2067
21 ex107.htm EX-FILING FEES 15588
  Complete submission text file 0001493152-23-017939.txt   3529153
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

IRS No.: 000000000
Type: F-1 | Act: 33 | File No.: 333-272005 | Film No.: 23931677
SIC: 2836 Biological Products, (No Diagnostic Substances)